Business Description
Universal Ibogaine Inc
NAICS : 541710
SIC : 3741
ISIN : CA91360F1099
Description
Universal Ibogaine Inc is in the initial stages of implementing and financing its business plan, which is to develop a network of addiction treatment clinics and to undertake a planned clinical trial for research in Canada into the use of ibogaine, a natural plant-based substance, for addiction treatment. Its mission is to redefine the addiction recovery experience, providing those living with addiction the best possible recovery.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 64.1 | |||||
9-Day RSI | 54.66 | |||||
14-Day RSI | 51.19 | |||||
3-1 Month Momentum % | 170 | |||||
6-1 Month Momentum % | 748.57 | |||||
12-1 Month Momentum % | 62.3 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Margin % | -32.16 | |||||
OCF Margin % | -31.08 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -10.93 | |||||
EV-to-EBITDA | -14.82 | |||||
EV-to-Revenue | 7.02 | |||||
EV-to-FCF | -21.82 | |||||
Earnings Yield (Greenblatt) % | -9.15 | |||||
FCF Yield % | -5.49 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:IBOGF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Universal Ibogaine Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.48 | ||
| EPS (TTM) ($) | -0.015 | ||
| Beta | 10.9366 | ||
| 3-Year Sharpe Ratio | 0.76 | ||
| 3-Year Sortino Ratio | 3.5 | ||
| Volatility % | 647.84 | ||
| 14-Day RSI | 51.19 | ||
| 14-Day ATR ($) | 0.005851 | ||
| 20-Day SMA ($) | 0.026125 | ||
| 12-1 Month Momentum % | 62.3 | ||
| 52-Week Range ($) | 0.0023 - 0.35 | ||
| Shares Outstanding (Mil) | 312.86 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Universal Ibogaine Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Universal Ibogaine Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Universal Ibogaine Inc Frequently Asked Questions
What is Universal Ibogaine Inc(IBOGF)'s stock price today?
The current price of IBOGF is $0.03. The 52 week high of IBOGF is $0.35 and 52 week low is $0.00.
When is next earnings date of Universal Ibogaine Inc(IBOGF)?
The next earnings date of Universal Ibogaine Inc(IBOGF) is .
Does Universal Ibogaine Inc(IBOGF) pay dividends? If so, how much?
Universal Ibogaine Inc(IBOGF) does not pay dividend.
Guru Commentaries on OTCPK:IBOGF
No articles.
Press Release
Articles on Universal Ibogaine Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers